2017 Annual Meeting

Session: Materials Science in Pharmaceutical Process Development II

Material science understanding is a key factor to consider in drug substance and drug product process development. The material properties for the API, excipients, and intermediates can influence the process and product performance. This session focuses on the application of material science to guide drug substance and drug product development. Of particular interest is work related to elucidate key material attributes impacting process and product performance as well as the application of the novel material property tool or data to gain further process understanding.

Chair

Jason Mustakis, Pfizer Inc.

Co-Chair

Lei Zhu, Merck & Co.

Presentations

12:30 PM

12:52 PM

M. Sebastian Escotet-Espinoza, Gerardo Callegari, Marianthi Ierapetritou, Fernando Muzzio

01:14 PM

Wenzhao Yang, Jin Zhao, Jaime Curtis-Fisk, Karen Balwinski, TRUE Rogers, Shrikant Khot

01:36 PM

Jens Dhondt, Ashish Kumar, Bernd Van Snick, Johny Bertels, Didier Klingeleers, Chris Vervaet, Thomas De Beer

01:58 PM

02:20 PM

Sandra Stranzinger, Eva Faulhammer, Otto Scheibelhofer, Vittorio Calzolari, Stefano Biserni, Amrit Paudel, Johannes G. Khinast

02:42 PM

Nastaran Ghazi, Zhanjie Liu, Zhiwei Cao, Chinmay Bhat, San Kiang, Alberto Cuitino